Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2001
11/22/2001WO2001019976A3 Plant regulatory sequences for control of gene expression
11/22/2001WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby
11/22/2001WO2001007637B1 Conditionally controlled, attenuated hiv vaccine
11/22/2001WO2000070089A9 Cdx2 is downstream mediator of apc tumor suppressor activity
11/22/2001WO2000070022A9 Ex vivo expansion of mammalian hematopoietic stem cells
11/22/2001US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy
11/22/2001US20010044525 Fibroblast growth factor (FGF); antibodies, expression vectors, fusion proteins; culturing mesenchymal stem cells or progenitor cells in presence of zFGF12 to stimulate cell proliferation
11/22/2001US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001US20010044436 Bicyclic inhibitors of glycogen synthase kinase 3
11/22/2001US20010044150 Method for transformation of animal cells
11/22/2001US20010044149 Transfer of heterologous gene sequences into cells using equine infectious anemia virus-derived vectors for gene delivery
11/22/2001US20010044148 EBV-infected stomach cancer cell line
11/22/2001US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins
11/22/2001US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor
11/22/2001US20010044122 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations
11/22/2001US20010044100 Messenger RNA is used as a target (marker) which exists mainly on float in the cytoplasm and is a transcriptional product of a gene instead of using the translation product.
11/22/2001US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination
11/22/2001US20010043921 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides
11/22/2001US20010043919 Proliferation of hepatocyte precursors
11/22/2001US20010043918 Biosynthesis of a musculoskeletal tissue, e.g., bone, cartilage and ligaments, by placing the precursor, e.g. osteoblasts, in a culture vessel and applying at least one force on the tissue to respond to a desired physical property
11/22/2001CA2410181A1 Novel motor proteins and methods for their use
11/22/2001CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001CA2409703A1 Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use
11/22/2001CA2409506A1 Method for cell adhesion and wound healing
11/22/2001CA2409452A1 Methods for enriching for quiescent cells in hematopoietic cell populations
11/22/2001CA2409448A1 Methods for modulating the proliferation of hematopoietic cells
11/22/2001CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001CA2409361A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001CA2409148A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001CA2409141A1 Method for preventing allograft rejection
11/22/2001CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/22/2001CA2409102A1 Microinjection of cryoprotectants for preservation of cells
11/22/2001CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus
11/22/2001CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells
11/22/2001CA2408756A1 Immune potentiating compositions
11/22/2001CA2408745A1 Anti-angiogenic polypeptides
11/22/2001CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration
11/22/2001CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001CA2408530A1 Novel deoxynucleoside kinase enzyme variants
11/22/2001CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001CA2408503A1 Seven transmembrane proteins and polynucleotides encoding the same
11/22/2001CA2408433A1 Synthetic gagpol genes and their uses
11/22/2001CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy
11/22/2001CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
11/22/2001CA2408351A1 Lipid bilayer array methods and devices
11/22/2001CA2408246A1 Cell line for the expression of an .alpha.2.delta.2 calcium channel subunit
11/22/2001CA2408134A1 G-protein coupled receptors
11/22/2001CA2407104A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
11/22/2001CA2404822A1 Fertilization of aged oocytes
11/22/2001CA2398979A1 Novel bee venom polypeptides and methods of use thereof
11/21/2001EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction
11/21/2001EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes
11/21/2001EP1156116A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defense
11/21/2001EP1156112A1 Synthetic gagpol genes and their uses
11/21/2001EP1156111A1 Chimeric arterivirus-like particles
11/21/2001EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001EP1156106A1 Novel enzyme having decoloring activity and method for decoloring dyes by using the same
11/21/2001EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma
11/21/2001EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives
11/21/2001EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity
11/21/2001EP1155134A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants
11/21/2001EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes
11/21/2001EP1155130A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems
11/21/2001EP1155118A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of somatic cells
11/21/2001EP1155116A1 Use of collagenase in the preparation of neural stem cell cultures
11/21/2001EP1155115A1 Method of modifying cytotoxic cells and uses thereof
11/21/2001EP1155114A1 Avian pluripotent embryonic germ cell line
11/21/2001EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase
11/21/2001EP1155028A1 Pigment protein from coral tissue
11/21/2001EP1154801A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
11/21/2001EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001EP1154788A1 Inhibitors of separin, method for identifying them and uses
11/21/2001EP1154786A2 Methods and compositions for altering mucus secretion
11/21/2001EP1154780A2 Bone marrow transplantation for hepatic regeneration and repair
11/21/2001EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001EP1154686A1 Method for inhibiting transplant rejection
11/21/2001EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001EP0773962B1 Antibodies which activate an erythropoietin receptor
11/21/2001EP0767676B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions
11/21/2001EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors
11/21/2001EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen
11/21/2001EP0536186B1 Bone and cartilage inductive proteins
11/21/2001CN1323354A Characterisation of gene function using double stranded RNA inhibition
11/21/2001CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof
11/21/2001CN1323349A Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
11/21/2001CN1323348A Delivery system for porcine somatotropin
11/21/2001CN1323347A Means and methods for modulating stomata characteristica in plants
11/21/2001CN1323346A TPL-2/COT kinase and methods of use
11/21/2001CN1323181A Method and device for preparing a dental implant by immersion in a mesenchymal cell culture
11/21/2001CN1322816A Method of separating megakaryo archeocyte
11/21/2001CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001CN1075078C Producing process of stem cell factor
11/20/2001US6320103 Transgenic plants with intensified osmotolerance
11/20/2001US6320100 Synthetic DNA sequences having enhanced insecticidal activity in maize
11/20/2001US6320097 Nucleotide sequences for use as genetic engineering tools; for use in expression of heterologous proteins
11/20/2001US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics